{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=New+Haven&page=8&state=Connecticut", "query": { "state": "Connecticut", "city": "New Haven", "page": 8 }, "page_size": 10 }, "pagination": { "page": 8, "page_size": 10, "total_count": 1348, "total_pages": 135, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=New+Haven&page=9&state=Connecticut&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=New+Haven&page=7&state=Connecticut&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-30T21:52:48.182Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00385632", "title": "Effects of Two Anti-HIV Drug Regimens on Quality of Life and Health Care Use Among SMART Study Participants", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Antiretroviral Regimens", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": null, "sex": "ALL", "summary": "13 Years and older" }, "enrollment_count": 1224, "start_date": "2002-01", "completion_date": "2008-11", "has_results": false, "last_update_posted_date": "2014-04-21", "last_synced_at": "2026-10-30T21:52:48.182Z", "location_count": 67, "location_summary": "Fresno, California • Mill Valley, California • Oakland, California + 32 more", "locations": [ { "city": "Fresno", "state": "California" }, { "city": "Mill Valley", "state": "California" }, { "city": "Oakland", "state": "California" }, { "city": "Oakland", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00385632" }, { "nct_id": "NCT05986292", "title": "A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Osteoarthritis, Knee", "Diabetic Neuropathic Pain", "Chronic Low-back Pain" ], "interventions": [ { "name": "LY3016859 ISA", "type": "DRUG" }, { "name": "LY3556050 ISA", "type": "DRUG" }, { "name": "LY3526318 ISA", "type": "DRUG" }, { "name": "LY3857210 ISA", "type": "DRUG" }, { "name": "Placebo Oral", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "LY4065967 ISA", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10000, "start_date": "2020-01-30", "completion_date": "2027-04", "has_results": false, "last_update_posted_date": "2026-09-23", "last_synced_at": "2026-10-30T21:52:48.182Z", "location_count": 62, "location_summary": "Birmingham, Alabama • Glendale, Arizona • Phoenix, Arizona + 52 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT05986292" }, { "nct_id": "NCT02864953", "title": "Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Brain Edema", "Stroke, Acute" ], "interventions": [ { "name": "BIIB093", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Remedy Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 535, "start_date": "2018-08-29", "completion_date": "2023-08-18", "has_results": true, "last_update_posted_date": "2024-11-25", "last_synced_at": "2026-10-30T21:52:48.182Z", "location_count": 74, "location_summary": "Phoenix, Arizona • Tucson, Arizona • Palo Alto, California + 59 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Palo Alto", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02864953" }, { "nct_id": "NCT06206837", "title": "A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "vepdegestrant", "type": "DRUG" }, { "name": "PF-07220060", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 71, "start_date": "2024-02-19", "completion_date": "2027-05-25", "has_results": true, "last_update_posted_date": "2026-09-30", "last_synced_at": "2026-10-30T21:52:48.182Z", "location_count": 34, "location_summary": "Fayetteville, Arkansas • Rogers, Arkansas • Springdale, Arkansas + 22 more", "locations": [ { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Rogers", "state": "Arkansas" }, { "city": "Springdale", "state": "Arkansas" }, { "city": "Irvine", "state": "California" }, { "city": "Irvine", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06206837" }, { "nct_id": "NCT06022939", "title": "Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "AL Amyloidosis" ], "interventions": [ { "name": "Autologous Hematopoietic Stem Cell Transplantation", "type": "PROCEDURE" }, { "name": "Biopsy", "type": "PROCEDURE" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Bone Marrow Aspiration", "type": "PROCEDURE" }, { "name": "Bone Marrow Biopsy", "type": "PROCEDURE" }, { "name": "Bortezomib", "type": "DRUG" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Daratumumab and Hyaluronidase-fihj", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Echocardiography", "type": "PROCEDURE" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Melphalan", "type": "DRUG" }, { "name": "Positron Emission Tomography", "type": "PROCEDURE" }, { "name": "Stem Cell Isolation", "type": "PROCEDURE" }, { "name": "Survey Administration", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "DRUG", "OTHER" ], "sponsor": "SWOG Cancer Research Network", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 338, "start_date": "2024-07-01", "completion_date": "2030-10-29", "has_results": false, "last_update_posted_date": "2026-05-06", "last_synced_at": "2026-10-30T21:52:48.182Z", "location_count": 117, "location_summary": "Goodyear, Arizona • Tucson, Arizona • Duarte, California + 93 more", "locations": [ { "city": "Goodyear", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "Irvine", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06022939" }, { "nct_id": "NCT03762928", "title": "ESTIMATION OF THE EFFECT OF MULTIPLE DOSE PF-06651600 ON THE PHARMACOKINETICS OF SINGLE DOSE MIDAZOLAM AND EFAVIRENZ", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Subjects" ], "interventions": [ { "name": "PF-06651600", "type": "DRUG" }, { "name": "midazolam", "type": "DRUG" }, { "name": "efavirenz", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 12, "start_date": "2018-12-07", "completion_date": "2019-02-21", "has_results": false, "last_update_posted_date": "2019-03-26", "last_synced_at": "2026-10-30T21:52:48.182Z", "location_count": 1, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT03762928" }, { "nct_id": "NCT02579265", "title": "Phase 3 Study to Compare Safety and Efficacy of Smoflipid 20% to Intralipid 20% in Hospitalized Neonates and Infants", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hospitalized Neonates and Infants, Expected to Require Parenteral Nutrition for 28 Days" ], "interventions": [ { "name": "Smoflipid 20% (investigational lipid for parenteral nutrition)", "type": "DRUG" }, { "name": "Intralipid® 20%", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Fresenius Kabi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "0 Weeks", "maximum_age": null, "sex": "ALL", "summary": "0 Weeks and older" }, "enrollment_count": 204, "start_date": "2015-12", "completion_date": "2020-04-10", "has_results": true, "last_update_posted_date": "2022-01-05", "last_synced_at": "2026-10-30T21:52:48.182Z", "location_count": 13, "location_summary": "Palo Alto, California • San Diego, California • New Haven, Connecticut + 8 more", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02579265" }, { "nct_id": "NCT03007407", "title": "Study of Durvalumab and Tremelimumab After Radiation for Microsatellite Stable Metastatic Colorectal Cancer Progressing on Chemotherapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Colorectal Cancer Metastatic" ], "interventions": [ { "name": "durvalumab", "type": "DRUG" }, { "name": "Tremelimumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NSABP Foundation Inc", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 33, "start_date": "2017-07-31", "completion_date": "2019-08-09", "has_results": true, "last_update_posted_date": "2022-12-05", "last_synced_at": "2026-10-30T21:52:48.182Z", "location_count": 18, "location_summary": "Duarte, California • New Haven, Connecticut • North Haven, Connecticut + 11 more", "locations": [ { "city": "Duarte", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "North Haven", "state": "Connecticut" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03007407" }, { "nct_id": "NCT06136195", "title": "Influence of Mavoglurant on Alcohol Craving and Drinking in Heavy Drinkers", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Alcohol Consumption", "Heavy Drinker", "Alcohol Use Disorder (AUD)" ], "interventions": [ { "name": "Mavoglurant", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Yale University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "21 Years to 50 Years" }, "enrollment_count": 63, "start_date": "2024-07-01", "completion_date": "2028-05-31", "has_results": false, "last_update_posted_date": "2026-08-21", "last_synced_at": "2026-10-30T21:52:48.182Z", "location_count": 2, "location_summary": "New Haven, Connecticut", "locations": [ { "city": "New Haven", "state": "Connecticut" }, { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT06136195" }, { "nct_id": "NCT01592136", "title": "Expanded Access Program of Ponatinib", "overall_status": "APPROVED_FOR_MARKETING", "study_type": "EXPANDED_ACCESS", "phases": [], "conditions": [ "Chronic Myeloid Leukemia (CML)", "Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)" ], "interventions": [ { "name": "ponatinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ariad Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": null, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2018-02-06", "last_synced_at": "2026-10-30T21:52:48.182Z", "location_count": 33, "location_summary": "La Jolla, California • San Marcos, California • Vallejo, California + 28 more", "locations": [ { "city": "La Jolla", "state": "California" }, { "city": "San Marcos", "state": "California" }, { "city": "Vallejo", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Altamonte Springs", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01592136" } ] }